 SOUTH SAN FRANCISCO, Calif., Oct. 07, 2021 GLOBE NEWSWIRE -- Global Blood Therapeutics, Inc. GBT NASDAQ: GBT today announced that on October 1, 2021, the compensation committee of GBTs board of directors granted 22 new employees restricted stock units for an aggregate of 54,750 shares of the companys common stock. These awards were made under GBTs Amended and Restated 2017 Inducement Equity Plan the Plan. 